UNICREDIT BANK/CALL/ASTRAZENECA/12500/0.1/18.09.24 Share Price

Warrant

DE000HD137V5

Market Closed - Börse Stuttgart 12:24:06 18/05/2024 am IST
0.6 EUR -4.76% Intraday chart for UNICREDIT BANK/CALL/ASTRAZENECA/12500/0.1/18.09.24
Current month-3.23%
1 month+130.77%
Date Price Change
17/24/17 0.6 -4.76%
16/24/16 0.63 -4.55%
15/24/15 0.66 -9.59%
14/24/14 0.73 -1.35%
13/24/13 0.74 -6.33%

Delayed Quote Börse Stuttgart

Last update May 18, 2024 at 12:24 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ASTRAZENECA PLC
IssuerLogo Issuer UniCredit UniCredit
WKN HD137V
ISINDE000HD137V5
Date issued 04/12/2023
Strike 12,500 p
Maturity 18/09/2024 (124 Days)
Parity 10 : 1
Emission price 0.25
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.84
Lowest since issue 0.037
Delta0.48x
Omega 11.03
Premium7.57x
Gearing23.01x
Moneyness 0.9688
Difference Strike 390 p
Difference Strike %+3.12%
Spread 0.03
Spread %4.76%
Theoretical value 0.6150
Implied Volatility 21.50 %
Total Loss Probability 57.01 %
Intrinsic value 0.000000
Present value 0.6150
Break even 13,026.27 €
Theta-0.03x
Vega0.03x
Rho0.02x

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
153.9 USD
Average target price
167.6 USD
Spread / Average Target
+8.90%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW